Omnicell Reports Second Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Omnicell (OMCL) Tops Q2 EPS by 14c, Revenues Beat; Offers 3Q EPS Outlook Below Consensus, 3Q Revenue Mid-Point Guidance Below Consensus
July 28, 2020 4:04 PM EDTOmnicell (NASDAQ: OMCL) reported Q2 EPS of $0.37, $0.14 better than the analyst estimate of $0.23. Revenue for the quarter came in at $199.6 million versus the consensus estimate of $182.42 million.
GAAP revenues of $199.6 million and net loss per diluted share of $0.10Non-GAAP revenues $199.6 million and net income per diluted share of $0.37Omnicells Response to Coronavirus (COVID-19)
Keeping in mind our role in the healthcare industry, we are continuing to closely monitor the COVID-19 pandemic. Our top priorities remain protecting the health and well-being of our customers, their patients, and our... More
